Jeff E. Knight Insider Profile
4 Followers
Jeff E. Knight, Chief Dev. & Operating Officer at Crinetics Pharmaceuticals, holds 105.29K shares in Crinetics Pharmaceuticals (Ticker: CRNX), holds ― shares in ALX Oncology Holdings (Ticker: ALXO).
Jeff E. Knight Crinetics Pharmaceuticals (CRNX)Chief Dev. & Operating Officer
Crinetics Pharmaceuticals (CRNX)
Chief Dev. & Operating Officer
Ranked #47,241 out of 107,514 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+11.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeff E. Knight holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 26, 2024 - Mar 26, 2025
Return:+20.40%
The most profitable trade made by Jeff E. Knight
Jeff E. Knight's Trading History
Crinetics Pharmaceuticals
Apr 10, 2026
Chief Dev. & Operating Officer
Uninformative Buy
1.76M
$3.87M
ALX Oncology Holdings
―
Chief Dev & Operating Officer
―
―
List of latest transactions for each holding click on a transaction to see Jeff E. Knight's performance on stock
You May Also Like
Jeff E. Knight insider profile FAQ
What is the percentage of profitable transactions made by Jeff E. Knight?
The percentage of profitable transactions made by Jeff E. Knight is 100%.
What is the average return per transaction made by Jeff E. Knight?
The average return per transaction made by Jeff E. Knight is 11.20%.
What stocks does Jeff E. Knight hold?
Jeff E. Knight holds: CRNX, ALXO stocks.
What was Jeff E. Knight’s latest transaction?
Jeff E. Knight latest transaction was an Uninformative Buy of $1.76M.
What was Jeff E. Knight's most profitable transaction?
Jeff E. Knight’s most profitable transaction was an Informative Sell of CRNX stock on March 26, 2024. The return on the trade was 20.40%.
What is Jeff E. Knight's role in Crinetics Pharmaceuticals?
Jeff E. Knight's role in Crinetics Pharmaceuticals is Chief Dev. & Operating Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.